Comment on “Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study”

American Journal of Transplantation · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles